You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

SV2A

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cannabis Use Disorder, Healthy Trial in New Haven ([11C]APP311)

Recruiting
  • Cannabis Use Disorder
  • Healthy
  • New Haven, Connecticut
    Yale University School of Medicine
Jul 20, 2022

HIV Associated Neurocognitive Disorder, HIV Dementia, HIV Encephalitis Trial (SV2A PET, TSPO PET)

Not yet recruiting
  • HIV Associated Neurocognitive Disorder
  • +3 more
  • SV2A PET
  • TSPO PET
  • (no location specified)
Oct 16, 2022

Cannabis Use Trial in New Haven ([11C]UCB-J PET)

Recruiting
  • Cannabis Use
  • [11C]UCB-J PET
  • New Haven, Connecticut
    Connecticut Mental Health Center
Aug 17, 2022

MDD, Anhedonia Trial in Saint Louis (Psilocybin)

Withdrawn
  • Major Depressive Disorder
  • Anhedonia
  • Saint Louis, Missouri
    Washington University School of Medicine
Jan 26, 2023

Alzheimer Trial in Madison (UCB-J)

Recruiting
  • Alzheimer Disease
  • Madison, Wisconsin
    University of Wisconsin
Apr 27, 2022

Tau Protein and SV2a Imaging in Tau Protein-related Diseases

Recruiting
  • Alzheimer Disease
  • +2 more
    • Beijing, Beijing, China
      Xuanwu Hospital
    Feb 28, 2022

    Alzheimer Trial in New Haven (Active Treatment- CT1812 100 mg, Placebo, Active Treatment- CT1812 300 mg)

    Completed
    • Alzheimer Disease
    • Active Treatment- CT1812 100 mg
    • +2 more
    • New Haven, Connecticut
      Yale University School of Medicine
    Jan 10, 2022

    Cognitive Change Trial in Riverside, Madison (C1 - Standard Perceptual Learning (SPL), C2 - Long Training (LT), C3 - Short

    Recruiting
    • Cognitive Change
    • C1 - Standard Perceptual Learning (SPL)
    • +12 more
    • Riverside, California
    • +1 more
    May 31, 2023

    Relapsing Multiple Sclerosis Trial in Worldwide (fenebrutinib, )

    Recruiting
    • Relapsing Multiple Sclerosis
    • Fullerton, California
    • +16 more
    Jan 24, 2023

    Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), Coronavirus Disease 2019 (COVID-19), Immunocompromised Trial

    Not yet recruiting
    • Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
    • +4 more
    • Cooperstown, New York
    • +10 more
    Dec 11, 2022

    Coronary Artery Disease Trial in Japan (Device: Paclitaxel-Coated PTCA Balloon Catheter, SeQuent Please Drug Eluting Balloon

    Active, not recruiting
    Has Results
    • Coronary Artery Disease
    • Device: Paclitaxel-Coated PTCA Balloon Catheter
    • SeQuent Please Drug Eluting Balloon Catheter with Paclitaxel
    • Kitakyushu, Fukuoka, Japan
    • +13 more
    Dec 2, 2022

    Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, Prognostic Stage IV Breast Cancer AJCC v8 Trial in

    Withdrawn
    • Anatomic Stage IV Breast Cancer AJCC v8
    • +4 more
    • Philadelphia, Pennsylvania
      Sidney Kimmel Cancer Center at Thomas Jefferson University
    Jun 3, 2021

    Schizophrenia Trial in Worldwide (Luvadaxistat, Placebo)

    Completed
    • Schizophrenia
    • Garden Grove, California
    • +53 more
    Dec 7, 2021

    Breastcancer, Breast Tumor Trial in United States (SV-BR-1-GM, Cyclophosphamide, Interferon-alpha-2b)

    Completed
    Has Results
    • Breastcancer
    • Breast Neoplasm
    • SV-BR-1-GM
    • +2 more
    • Santa Rosa, California
    • +4 more
    Jan 27, 2021

    Diabetic Foot Ulcer (DFU) Trial in Worldwide (APO-2, Placebo)

    Recruiting
    • Diabetic Foot Ulcer (DFU)
    • APO-2
    • Placebo
    • Graz, Austria
    • +13 more
    Apr 7, 2022

    Gram-Positive Infections Trial in Worldwide (IV Tedizolid Phosphate, Oral Suspension Tedizolid Phosphate)

    Recruiting
    • Gram-Positive Infections
    • IV Tedizolid Phosphate
    • Oral Suspension Tedizolid Phosphate
    • Little Rock, Arkansas
    • +27 more
    Aug 18, 2022

    Breast Cancer Female, Breast Tumor Female Trial in United States (SV-BR-1-GM, INCMGA00012, Low dose cyclophosphamide)

    Recruiting
    • Breast Cancer
    • +3 more
    • SV-BR-1-GM
    • +3 more
    • Newport Beach, California
    • +9 more
    Dec 8, 2022

    Periodic Breathing, Cheyne-Stokes Respiration Trial in Weg (Adaptive Servo-controlled Ventilation (ASV))

    Completed
    • Periodic Breathing
    • Cheyne-Stokes Respiration
    • Adaptive Servo-controlled Ventilation (ASV)
    • Weg, Essen, Germany
      Ruhrland Hospital
    Feb 2, 2021

    Vertebral Compression Fracture, Vertebral Compression, Vertebral Fracture Trial in Frankfurt, Offenbach, Barcelona (AGN1 LOEP SV

    Recruiting
    • Vertebral Compression Fracture
    • +2 more
    • AGN1 LOEP SV Kit
    • Frankfurt, Hessen, Germany
    • +3 more
    Nov 28, 2022

    Glaucoma, Open-Angle Trial (Interposition supraciliary implant)

    Recruiting
    • Glaucoma, Open-Angle
    • Interposition supraciliary implant
    • Yerevan, Armenia
      Malayan center
    Nov 22, 2022

    Chronic Hand Eczema (CHE) Trial in Worldwide (Ruxolitinib cream, Vehicle)

    Withdrawn
    • Chronic Hand Eczema (CHE)
    • Birmingham, Alabama
    • +38 more
    Nov 7, 2022

    Leukemia, Lymphocytic, Chronic, B-Cell Trial in Bulgaria, Georgia, Poland (Tenalisib)

    Completed
    Has Results
    • Leukemia, Lymphocytic, Chronic, B-Cell
    • Pleven, Bulgaria
    • +5 more
    Jul 22, 2021

    NASH - Nonalcoholic Steatohepatitis Trial in Worldwide (Namodenoson, Placebo)

    Recruiting
    • NASH - Nonalcoholic Steatohepatitis
    • Banja Luka, Bosnia and Herzegovina
    • +29 more
    May 20, 2022

    Multiple Sclerosis Trial in Worldwide (Mavenclad®)

    Completed
    Has Results
    • Multiple Sclerosis
    • Sydney, New South Wales, Australia
    • +53 more
    Jul 25, 2022

    Systemic Lupus Erythematosus Trial in Worldwide (GLPG3970 film-coated tablet, Placebo film-coated tablet)

    Terminated
    • Systemic Lupus Erythematosus
    • GLPG3970 film-coated tablet
    • Placebo film-coated tablet
    • Pleven, Bulgaria
    • +13 more
    Oct 14, 2021